NASDAQ:LGVN
Longeveron Inc. Stock News
$1.75
+0.0800 (+4.79%)
At Close: Apr 26, 2024
7 Penny Stocks to Buy to Sidestep the Noise on Wall Street
10:21am, Thursday, 21'st Oct 2021
With so much chaos occurring on Wall Street, these lesser-known penny stocks to buy might fly profitably under the radar. The post 7 Penny Stocks to Buy to Sidestep the Noise on Wall Street appeared f
New York, New York--(Newsfile Corp. - October 18, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Longeveron Inc. ("Longeveron" or the "Company") (NASDAQ: LGVN) an
New York, New York--(Newsfile Corp. - October 15, 2021) - WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant
2 Moonshot Stocks Insiders Have Suddenly Started Buying
04:54pm, Friday, 15'th Oct 2021
Insider trading is a fact of life, which means that following the insiders might be the best way to win. Here's how to make good choices.
Longeveron to Present at the 2021 Dawson James Securities 6th Annual Small Cap Growth Conference
08:00am, Thursday, 14'th Oct 2021
CEO Geoff Green to highlight Longeveron's progress in Alzheimer's disease, Aging Frailty, and Hypoplastic Left Heart Syndrome clinical research programs CEO Geoff Green to highlight Longeveron's progr
LGVN Stock: Why It Increased Today
05:07am, Thursday, 14'th Oct 2021
The stock price of Longeveron Inc (NASDAQ: LGVN) increased by over 6% pre-market today. This is why it happened.
NEW YORK, Oct. 13, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant and/or traceable to
New York, New York--(Newsfile Corp. - October 12, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion no late
New York, New York--(Newsfile Corp. - October 9, 2021) - Pomerantz LLP announces that a class action lawsuit has been filed against Longeveron Inc. ("Longeveron" or the "Company") (NASDAQ: LGVN) and c
NEW YORK--(BUSINESS WIRE)--WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant and/or traceable to the Offering
New York, New York--(Newsfile Corp. - October 7, 2021) - Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion no later
NEW YORK, Oct. 6, 2021 /PRNewswire/ -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Longeveron Inc. (NASDAQ: LGVN): (1) pursuant and/or traceable to
NEW YORK, Oct. 5, 2021 /PRNewswire/ -- Bernstein Liebhard, a nationally acclaimed investor rights law firm, reminds investors of the deadline to file a lead plaintiff motion no later than November 12
Los Angeles, California--(Newsfile Corp. - October 4, 2021) - The Schall Law Firm, a national shareholder rights litigation firm, announces the filing of a class action lawsuit against Longeveron In
Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment
08:43am, Monday, 04'th Oct 2021
Research and development of stem cell-based therapies, where a patient's own cells, or those from a donor, are used to fight injury and disease, is one of the fastest growing areas in the biotech spac
